Kalyanasundaram Subramanian is the CEO and Co-Founder of Differentia Bio, a company that provides modeling services to the pharma industry. He has more than 25 years of experience in applying modeling to drug discovery and development across a broad range of therapeutic areas and treatment modalities along with more than 20 years of executive-level experience at Applied Biomath LLC, Syngene International, Strand Life Sciences Pvt. Ltd and Entelos. He also helped found a group to perform research in synthetic and hybrid vectors for gene delivery at Genetic Therapy Inc (Novartis). He has a B. Tech in Chemical Engineering from IIT Bombay, an MS from SUNY at Buffalo and a PhD in Biomedical Engineering from the Johns Hopkins University
